Tag: Regulation
Anti-Authoritarian Authoritarians
Many readers of The Beacon will know that Florida Governor Ron DeSantis has issued an executive order prohibiting governments in Florida from mandating that people wear masks. Meanwhile, many local government officials, including my local school board and superintendent, have defied that order and issued mask mandates. In response, the governor and state commissioner...
Read More »
How Governments Botched COVID-19 Testing, Reinforcing Destructive Lockdowns and Massive “Relief” Spending
By Lawrence J. McQuillan and Jonathan Hofer The most glaring governmental failure during the COVID-19 experience in the United States has been the botched testing strategy because it allowed government authorities to “justify” devastating lockdowns and massive “relief” spending. But the lockdowns and spending could have been avoided had better testing been pursued from...
Read More »
Entrepreneurial Economies
Academic institutions increasingly are recognizing the importance of entrepreneurship to the performance of an economy, and in response, many (including my own institution, Florida State University) have established entrepreneurship programs to give students some skills that can help them succeed as entrepreneurs. I’m supportive of these efforts, but the degree to which individuals in...
Read More »
To Mask, Or Not? A State of Resistance
The state of resistance, in this case, is Florida. Many readers will be aware that Florida Governor Ron DeSantis has prohibited mask mandates in the state, and faced some resistance from local school boards that have imposed mask mandates in defiance of the governor’s prohibition. Meanwhile, where I teach, at Florida State University, the...
Read More »
It’s Time to End the COVID Mandates
As everyone is aware, governments have been mandating restrictions on people’s behavior in response to the COVID pandemic for more than a year. Cases are on the rise around the US, and in response, governments are retaining existing mandates and reimposing mandates that had previously been repealed. COVID is not going away, but the...
Read More »
Ecstasy Nears FDA Approval to Treat Severe Post-Traumatic Stress Disorder
In a heart-wrenching story written in 2017, Rachael Kaplan details her lifelong struggles with Post Traumatic Stress Disorder (PTSD). Enduring chronic and severe abuse as a child, Rachael strongly considered ending her life and found herself “praying to die.” She worked with several therapists and numerous multiple treatment methods to improve her condition. Unfortunately,...
Read More »
Supreme Court Grants Injunction on California COVID Restrictions
On Friday, the Supreme Court in Tandon v. Newsom (2021), granted a request for injunctive relief related to California COVID restrictions banning Bible study and prayer meetings in private homes when more than three households are represented. The vote was 5-4, with Chief Justice Roberts and the Court’s liberal wing voting in the minority....
Read More »
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions
After a sluggish and error-prone beginning to a country-wide effort to vaccinate Americans against Covid-19, it seems things are quickly improving. According to the Centers for Disease Control, as of March 18th, nearly 113 million Americans have received at least Covid-19 vaccination (two of the three available vaccines require two separate injections). The agency...
Read More »
Social Media Platform Bias: It’s Their Right, But...
Social media platforms like Facebook, Twitter, and Instagram have de-platformed some (most notably, Donald Trump) and have been censoring the posts of others. Google has adjusted their “search algorithms” so that left-leaning results dominate sources from the political right. I’ve seen a lot of people who lean toward limited government support government intervention to...
Read More »
The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug
In March 2019, an experimental drug designed to treat Alzheimer’s disease named aducanumab failed a futility test during the process for approval from the Food and Drug Administration. Facing seemingly little hope for success, aducanumab’s producers Biogen and Eisai strongly considered abandoning the project. However, when the drugmakers conducted further analysis on a larger...
Read More »
  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org